Telik Inc.
Symbol:
TELK
Exchange:
Nasdaq
Industry:
Healthcare
Products:
Drugs
Company Website: Click Here
Company Info: Click Here
Quote and News: Click Here
Profiled Price:
$0.80
(October 09)
Company Snapshot:
Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA®, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.
|
